Cargando…
Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma
Ewing sarcoma is the second-most-common bone cancer in children. Driven by an oncogenic chromosomal translocation that results in the expression of an aberrant transcription factor, EWS/FLI, the disease is typically aggressive and micrometastatic upon presentation. Silencing of EWS/FLI in patient-de...
Autores principales: | Chaturvedi, Aashi, Hoffman, Laura M., Jensen, Christopher C., Lin, Yi-Chun, Grossmann, Allie H., Randall, R. Lor, Lessnick, Stephen L., Welm, Alana L., Beckerle, Mary C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161506/ https://www.ncbi.nlm.nih.gov/pubmed/25057021 http://dx.doi.org/10.1091/mbc.E14-01-0007 |
Ejemplares similares
-
EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma
por: Fadul, John, et al.
Publicado: (2015) -
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
por: Sankar, Savita, et al.
Publicado: (2012) -
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
por: Theisen, Emily R., et al.
Publicado: (2016) -
Microsatellites with Macro-Influence in Ewing Sarcoma
por: Monument, Michael J., et al.
Publicado: (2012) -
BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
por: Wiles, Elizabeth T., et al.
Publicado: (2013)